Cargando…
Mast Cell Activation Syndrome as a Significant Comorbidity in Sickle Cell Disease
Some sickle cell anemia (SCA) patients suffer significantly worse phenotypes than others. Causes of such disparities are incompletely understood. Comorbid chronic inflammation likely is a factor. Recently, mast cell (MC) activation (creating an inflammatory state) was found to be a significant facto...
Autor principal: | Afrin, Lawrence B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Journal of the Medical Sciences
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242119/ https://www.ncbi.nlm.nih.gov/pubmed/25171546 http://dx.doi.org/10.1097/MAJ.0000000000000325 |
Ejemplares similares
-
Utility of hydroxyurea in mast cell activation syndrome
por: Afrin, Lawrence B
Publicado: (2013) -
Post-HPV-Vaccination Mast Cell Activation Syndrome: Possible Vaccine-Triggered Escalation of Undiagnosed Pre-Existing Mast Cell Disease?
por: Afrin, Lawrence B., et al.
Publicado: (2022) -
Left Ventricular Rotational Mechanics in Tanzanian Children with Sickle Cell Disease
por: Di Maria, Michael V., et al.
Publicado: (2015) -
A survey of the currently known mast cell mediators with potential relevance for therapy of mast cell-induced symptoms
por: Molderings, Gerhard J., et al.
Publicado: (2023) -
Chemical Intolerance and Mast Cell Activation: A Suspicious Synchronicity
por: Palmer, Raymond F., et al.
Publicado: (2023)